EMAIL DETAILS
SUBJECT:
Introduction- Dennis Meheil
PRI: NORMAL
FROM:
H
hbiden@rosemontseneca.com
DATE:
2015-10-29 16:45:54
MSG_ID:
<CAD=XE+NnQDkNJ+wSBTKkXJgGLNeCFXc6mDP15iLjD8AQbuMTsw@mail.gmail.com>
RECIPIENTS:
TO:
C
Christopher A. Boies
<cboies@bsfllp.com>
L
lbarclay@bsfllp.com
CC:
J
Joan Peugh
<jmayer@rosemontseneca.com>
CONTENT:
TEXT: YES |
HTML: YES
PROCESSED
Chris- I got a call yesterday from Dennis Meheil, who you may know. He is currently the Chairman of U.S. Corrugated. Dennis has a relationship with a company called Northwest Biotherapeutics which produces a immunologic cancer drug that is currently undergoing testing by the FDA. They would like some help with the FDA process as they have hit some hurdles. I suggested that they hire Boies for this given Lisa’s expertise with the FDA. I have copied Lisa on this email as well. Ideally, I would like to organize an introduction for Lisa to Dennis and Northwest’s CEO as soon as possible. They are available any time to meet. Perhaps next Monday or Tuesday would work? Let me know how best to proceed and if you have any questions. I have copied Joan in my office who can help coordinate. Best, Hunter -- R. Hunter Biden Rosemont Seneca Partners, LLC 1010 Wisconsin Ave., NW Suite 705 Washington, DC 20007 (202) 333-188
METADATA:
THREAD:
INDEX:
AdhhpH0Kcp5ZcUHtTaG92m0owa0Mug==